174 related articles for article (PubMed ID: 2435632)
1. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
[TBL] [Abstract][Full Text] [Related]
3. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
4. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
5. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
6. [Acquired deficiencies in antithrombin III and C protein during treatment with L-asparaginase].
Mielot F; Danel P; Boyer C; Coulombel L; Dommergues JP; Tchernia G; Larrieu MJ
Arch Fr Pediatr; 1987 Mar; 44(3):161-5. PubMed ID: 2883953
[TBL] [Abstract][Full Text] [Related]
7. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
Matsuzaki A; Suminoe A; Hara T
Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
[TBL] [Abstract][Full Text] [Related]
10. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
[TBL] [Abstract][Full Text] [Related]
11. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
Shapiro RS; Gerrard JM; Ramsay NK; Nesbit ME; Coccia PF; Stoddard SF; Plow EF; White JG; Krivit W
Am J Pediatr Hematol Oncol; 1980; 2(3):207-12. PubMed ID: 6933865
[TBL] [Abstract][Full Text] [Related]
12. L-asparaginase-induced hypocomplementemia in acute lymphocytic leukemia (ALL) of childhood.
Shapiro R; Kim Y; Michael AF; Gerrard JM; Nesbit M; Coccia P; Ramsay NK; Krivit W
Am J Pediatr Hematol Oncol; 1979; 1(1):5-7. PubMed ID: 295575
[TBL] [Abstract][Full Text] [Related]
13. Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapy.
Barbui T; Rodeghiero F; Meli S; Dini E
Acta Haematol; 1983; 69(3):188-91. PubMed ID: 6404103
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
15. [L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
Bordigoni P; Briquel E; Olive D
Arch Fr Pediatr; 1981 Nov; 38(9):653-5. PubMed ID: 6949499
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
17. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase.
Dacou-Voutetakis C; Palis J; Haidas S; Zannos-Mariolea L; Georgiopoulou P; Matsaniotis N
Am J Pediatr Hematol Oncol; 1983; 5(2):139-46. PubMed ID: 6351658
[TBL] [Abstract][Full Text] [Related]
18. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.
Mitchell LG; Halton JM; Vegh PA; Barr RD; Venneri T; Pai KM; Andrew ME
Am J Pediatr Hematol Oncol; 1994 May; 16(2):120-6. PubMed ID: 8166364
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
[TBL] [Abstract][Full Text] [Related]
20. Increased antithrombin III concentration in children with acute lymphatic leukaemia receiving L-asparaginase therapy.
O'Meara A; Daly M; Hallinan FH
Med Pediatr Oncol; 1988; 16(3):169-74. PubMed ID: 3132590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
